# Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments

> **NCT01490697** · PHASE4 · COMPLETED · sponsor: **Roger K. Pitman, MD** · enrollment: 34 (actual)

## Conditions studied

- Post-traumatic Stress Disorder

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** d-Cycloserine
- **DRUG:** Placebo-matching Mifepristone
- **DRUG:** Placebo-matching d-Cycloserine (DCS)

## Key facts

- **NCT ID:** NCT01490697
- **Lead sponsor:** Roger K. Pitman, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490697, "Developing Memory Reconsolidation Blockers as Novel Posttraumatic Stress Disorder (PTSD) Treatments". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01490697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*